In Australia, many cosmetic injectable treatments are classified as Schedule 4 prescription-only medicine and are regulated by the TGA, Ahpra, and QLD Health.
Under these new regulations, clinics cannot publicly advertise injectable pricing, promotional offers, before & after images, or product-specific information relating to prescription-only treatments.

Rejuran

REJURAN® is a bio-regenerative injectable treatment formulated with highly purified polynucleotides (PN) derived from wild salmon DNA. These highly biocompatible polynucleotides are delivered directly into the skin to support skin quality and overall physiological function from within. They are designed to support the skin’s natural repair and renewal processes, help calm unwanted inflammation, and promote healthier-looking, more resilient skin over time.

REJURAN® works at a cellular level to improve overall skin quality, resilience, and balance.

Schedule a personalised consultation with our Doctor who will work with you individually to assess suitability, explain potential outcomes, follow-up steps, and consider your personal goals. Please note that results differ among individuals, and any further planning will be guided during your consult. Potential risks and side effects will also be discussed during consultation.

Frequently Asked Questions

Doctor: Veronika Maini MED0004033947

Nurse Practitioner: Adele Holmes NMW0001896830

Registered Nurse: Kirby Petterson NMW0002010508

At our clinic, patient safety, ethical practice, and regulatory compliance are at the centre of everything we do.
In Queensland and throughout Australia, cosmetic injectable treatments are governed by strict advertising regulations set by the Therapeutic Goods Administration (TGA), the Australian Health Practitioner Regulation Agency (Ahpra), and Queensland Health.

Many cosmetic injectable products are classified as Schedule 4 prescription only medicines.
Under Australian law, prescription medications cannot be advertised directly to the public. This means clinics are restricted from promoting injectable treatments in ways that may encourage or influence consumers to seek prescription-only products.

As part of these regulations, clinics are unable to publicly advertise:

  • Injectable treatment pricing or promotional offers

  • Before and after images that imply prescription-only injectable outcomes

  • Brand names or product-specific advertising

  • Content that may create unrealistic expectations of results

These guidelines are designed to protect patients by ensuring treatment decisions are made through an appropriate medical consultation, rather than through advertising or social media marketing. Every face, skin type, and treatment plan is different, and a personalised consultation allows our qualified practitioners to assess your concerns, discuss suitability, explain potential risks and benefits, and create an individualised treatment approach tailored to you.

If you would like to learn more about treatment options, we invite you to book a private consultation with our experienced clinical team.
During your consultation, we can discuss your goals, suitability, expected outcomes, and provide a personalised treatment plan and pricing information in accordance with current Australian regulations.